PF 592379Alternative Names: PF-000592379; PF-592,379
Latest Information Update: 18 Nov 2013
At a glance
- Originator Pfizer
- Class Analgesics; Erectile dysfunction therapies; Morpholines; Small molecules
- Mechanism of Action Dopamine D3 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Erectile dysfunction; Pain